Pharmacy Category Day Tuesday, May 19, 2015

Transcription

1 Pharmacy Category Day Tuesday, May 19, :00 am - 8:30 am Health Equity Considerations in Pharmacy Practice Speaker: CDR Lori Hall, PharmD, USPHS, Program Consultant, Centers for Disease Control and Prevention This session will enhance the learners' understanding of key concepts associated with health equity. It will provide an overview of the mission to equitably serve populations that bear a high burden of diseases and examine national efforts to address health disparities. Further, this session will highlight the relationship between health equity and pharmacy practice, and introduce tools and resources that pharmacists can use to apply these principles in their practice settings. 1. Define the term health disparities and explain what factors heavily contribute to their existence. 2. Identify two to three examples of health disparities that exist in the United States. 3. Explain how the pharmacist can improve their role in serving diverse populations and achieving health equity. 8:30 am - 9:00 am Indian Health Service Recommendations for Chronic Pain Management and Opioid Overdose Prevention Speaker: LCDR Hillary Duvivier, PharmD BCPS NCPS, USPHS, Pharmacist, Indian Health Service This session will look at how pharmacists can play a key role in the appropriate use of opioids and management of chronic pain. In a variety of settings, pharmacists can take part in chronic pain assessment and monitoring of patients. Co-prescribing of intranasal naloxone can also be considered to further mitigate the risks with opioids. Pharmacists have been able to evaluate chronic pain patients, minimize risk, improve patient outcomes, and lessen the burden on primary care and emergency department providers throughout the Indian Health Service system. 1. Explain Indian Health Service recommendations outlined on the new pain management website including assessment and monitoring of chronic pain patients. 2. State the pharmacist s role in co-prescribing intranasal naloxone to highrisk patients for opioid overdose prevention.

2 3. Describe a pharmacist-managed multidisciplinary chronic pain management clinic. 9:00 am - 9:30 am Using Data to Improve Outcomes Speaker: LCDR Rodney Waite, PharmD, USPHS, Pharmacist, Federal Bureau of Prisons This session will attempt to address all of its objectives by shortly introducing the concepts and then providing examples of each concept in a practice setting. An attempt will be made to provide examples that are relevant to most pharmacy practice areas across a multitude of agencies. Additionally, ample time for questions will be allowed at transition points in the presentation based on audience reaction to the presentation. 1. Describe some of the newer outcomes-based reimbursement models. 2. Identify how different data analyses can be related to healthcare outcomes. 3. Summarize where data analysis could potentially go in the future. 9:30 am - 10:00 am Affordable Care Act (ACA) Speaker: LCDR Jacquelyne Ivery, PharmD, MPH, USPHS, Public Health Specialist, Prescription Benefit SME, Center for Medicare and Medicaid Services (CMS) This session will show how the rulemaking process works with regards to legislation specific to the prescription benefit portion of the ACA, preparing the proposed rule, and addressing and incorporating public comments. The presenter will show how policies are operationalized or developed into reviews to determine the quality of a formulary and if standards mandated in policy are met. The presenter will develop these reviews and also the level/type of issuer outreach to occur if formularies are found to be non-compliant. Finally, the presenter also will show how external stakeholders (the public) impact the development of reviews, tools and content and extent of issuer outreach. 1. Interpret how the prescription benefit portion legislation of ACA is applied 2. Compare prescription drug review tools available for state DOI use 3. Explain how formulary reviews are developed.

3 10:15 am - 10:45 am Bureau of Prison Wellness and Re-entry Program Speaker: LT Sandra Mathoslah, PharmD, USPHS, Pharmacist, Federal Bureau of Prisons This session will enhance and highlight the wellness portion of the established Bureau of Prisons' program called the Threshold Program. The vision for the wellness portion of the Threshold Program is to: decrease prescription usage for the inmates, decrease medication purchasing cost for the institution, reduce production labor/time for pharmacists and providers, reduce burden on society to provide medication for the inmates upon re-entry and other related benefits. 1. Describe the Bureau's re-entry program and multi-faceted benefits to the wellness piece of the program. 2. Identify objective and subjective assessment tools used in the program and results from the trial period. 3. Explain pharmacist involvement in preventative health. 10:45 am - 11:15 am Electronic Cigarettes: Public Health Challenges and Opportunities Speakers: CDR Dan Brum, PharmD, MBA, RAC, USPHS, Chief, Project Management Staff, Food and Drug Administration and CDR Alina Salvatore, PharmD, USPHS, Senior Regulatory Project Manager, Food and Drug Administration This session will provide an overview of electronic cigarettes with a focus on their evolution and the concerns raised by health experts and regulatory agencies regarding their potential risks and benefits. This session will include a description of the federal government s regulatory and research initiatives to maximize the potential benefits and minimize risks of electronic cigarette use. The presentation will also touch on FDAapproved OTC smoking cessation aids, traditional tobacco products, and heat-not-burn tobacco products. 1. Identify the components of electronic cigarettes and how they work 2. Explain concerns with product manufacturing, variability, and use 3. Describe the federal government s efforts to regulate and research electronic cigarettes

4 11:15 am - 11:45 am CPO Pharmacy Presentation Speaker: RADM Pamela Schweitzer, USPHS 11:45 am 12:30 pm Break 12:30 pm 2:00 pm Luncheon, Awards and Rose Ceremony 2:00 pm - 2:30 pm Communication and Interpersonal Skills in Healthcare Speaker: LCDR Susan Alu, Pharm.D., BCPS, NCPS, USPHS, Pharmacist, Federal Bureau of Prisons This session will provide an overview on the importance of good communication and interpersonal skills for overcoming challenges in the modern healthcare setting. Strong communication and interpersonal skills are essential for delivery of effective patient care, particularly with the challenges of electronic communication and health records. Officers will be re-energized in their commitment to facilitate relationships in a manner that motivates others to maximize their abilities, skills, and knowledge. 1. Describe the benefits of good communication and interpersonal skills in a variety of healthcare settings. 2. Identify strategies for promoting positive inter-professional relationships. 3. Explain common causes for miscommunication in oral and written communication. 2:30 pm - 3:00 pm Utilization of Health Technology to Improve Medication Use Speaker: CDR Renee Robinson, MPH, USPHS, Senior Researcher, Southcentral Foundation/Indian Health Service This session will examine how the US healthcare system could save hundreds of millions of dollars per year with improved medication adherence. Consequences of non-adherence include worsening health conditions, increased comorbidity, increased health care costs, and death. Many factors contribute to poor medication adherence: patient-related factors (e.g., poor health literacy, lack of involvement in the treatment decision making process), physician-related factors (e.g., ineffective communication,

5 care by multiple physicians), and healthcare system-related factors (e.g., limited access to care, lack of health information technology). Information technology can improve the quality, safety, and efficiency of healthcare delivery by improving provider and patient access to health information, reducing and/or preventing errors and adverse events, facilitating response to problems, and tracking events and providing feedback to improve processes. 1. Review the impact of medication non-adherence on the healthcare system. 2. Provide an overview of currently available health technology applications that improve medication safety and adherence. 3. Present health technology research being done within a tribally-owned and operated health care facility to improve treatment persistence. 3:15 pm - 3:45 pm Operations & Innovations in Clinical Trials Speaker: LCDR Tami Rodriguez, PharmD, BCPS, NCPS, USPHS, Chief Pharmacist FCI Edgefield, Federal Bureau of Prisons This presentation will discuss exciting developments in methods to decrease access barriers for clinical trials by bringing the trial to the patient s home, increase convenience, streamline data collection, and increase study efficiency through the use of mobile health technologies, telemedicine, sensors, and local or traveling providers. Clinical Trials are a reality for many Americans, and are often a last hope for patients with cancer or rare diseases. Traditional clinical trials are often inconvenient, inaccessible, and fail due to a lack of enrollment or dropouts. Recent advances create a flatter, more patient-centered model of clinical trial execution. 1. Describe current clinical trial methodologies and why they are not optimal from a patient s perspective. 2. Identify new methodologies which address challenges in clinical trial execution. 3. Describe electronic technologies which facilitate patient care and data collection regardless of geographic location.

6 3:45 pm - 4:15 pm Overview of the Strategic National Stockpile (SNS) Speakers: LCDR Gabriel McLemore, PharmD, USPHS, Quality Assurance Specialist, Centers for Disease Control and Prevention and LCDR Hai Lien Phung, PharmD, USPHS, Quality Assurance Specialist, Centers for Disease Control and Prevention This session will introduce the SNS to PHS pharmacy officers and familiarize them with the diverse collection of national countermeasures available during a deployment. The presentation will provide an overview of SNS and discuss its capabilities during emergency response scenarios such as natural disasters and bioterrorist attacks. 1. Summarize the roles and functions of SNS during public health emergencies. 2. Describe the three pillars of support to demonstrate how SNS responds during public health emergencies 3. Explain the Push Package, CHEMPACK, and Federal Medical Station (FMS) programs and their capabilities in response to emergencies. 4:15 pm - 5:15 pm Ebola Virus Disease - Meeting the Challenge [Discussion Panel] Speakers: CAPT James Minor, Pharm.D, USPHS (Ret), Clinical Pharmacy Practitioner, National Institutes of Health; CAPT Corrinne Kulick, PharmD, USPHS, Safety Evaluator Team Leader, Food and Drug Administration; CAPT Daniel Diggins, PharmD, BCPS, Inpatient Pharmacy Supervisor, Phoenix Indian Medical Center, Indian Health Service; CDR Selena Ready, PharmD, USPHS, Safety Evaluator, Food and Drug Administration; CDR Hollie Cook, PharmD, BCACP, USPHS, Pharmacist, Centers for Disease Control and Prevention; and LT Sandra Mathoslah, PharmD, USPHS, Pharmacist, Federal Bureau of Prisons This session will present a brief overview of the epidemiology of the current Ebola virus disease outbreak, its putative routes of transmission, clinical presentation and current management interventions. Commissioned Officer pharmacists recently deployed to West Africa will share their 'boots on the ground' experiences as they address how their teams safely applied current and evolving standards of care in the management of patients suffering with Ebola virus disease. 1. Summarize the history and epidemiological profile of the current Ebola virus disease outbreak, putative routes of transmission, clinical presentation and current treatment interventions. 2. Describe the current status of investigational antiviral drugs and vaccines in development for Ebola virus disease.

7 3. Explain the role of PHS pharmacists and allied PHS healthcare professionals deployed to West Africa in support of the US Interagency response to the Ebola crisis. 5:15 pm 5:30 pm Closing Remarks